🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patients with proliferative diabetic retinopathy or clinically significant ...
Status
Completed
Location
Ivey Eye Institute, St. Joseph's Health Care Centre
Start Date
2006-10
Trial ID
NCT00446381
Treatments Being Tested
Age related macula degeneration is one of the most common sight threatening...
Status
Terminated
Location
Department of Clinical Pharmacology, Medical University of Vienna
Start Date
2008-03
Trial ID
NCT00709657
Treatments Being Tested
Intravitreal pegaptanib for treatment of choroidal neovascularisation secon...
Status
Withdrawn
Location
LV Prasad Eye Institute
Start Date
2010-12
Trial ID
NCT01218230
Treatments Being Tested
Intravitreal injections of pegaptanib every 4 weeks will be efficacious in ...
Status
Completed
Location
Valley Retina Institute,PA
Start Date
2009-04
Trial ID
NCT01486238
Treatments Being Tested
The purpose of the study to assess the efficacy of pegaptanib sodium 0.3 mg...
Status
Completed
Location
Nagoya City University Hospital
Start Date
2010-05
Trial ID
NCT01100307
Treatments Being Tested
The purpose of the study is to determine whether pegaptanib sodium (Macugen...
Status
Completed
Location
Multiple Locations
Start Date
2002-10
Trial ID
NCT00040313
Treatments Being Tested
According to a recent estimate more than 280,000 people in the United State...
Status
Completed
Location
Wake Forest University Eye Center
Start Date
2009-03
Trial ID
NCT00790803
Treatments Being Tested
This research is being conducted to look at the effects of an intraocular d...
Status
Terminated
Location
The Johns Hopkins Hospital
Start Date
2006-06
Trial ID
NCT00346983
Treatments Being Tested
This research is being done to look at the effects of an experimental drug ...
Status
Terminated
Location
The Johns Hopkins Hospital
Start Date
2006-07
Trial ID
NCT00358423
Treatments Being Tested
Diabetic macular oedema (DME) is one of the leading causes of blindness in ...
Status
Completed
Location
Oxford Eye Hospital
Start Date
2011-01
Trial ID
NCT01175070
Treatments Being Tested